Human HCC cells express vascular endothelial growth factor (VEGF), which modulates growth and survival and it has been shown that treatment with DAAs leads to a marked increase in VEGF in patients with cirrhosis (a 4-fold increase) [30]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.